Sungmin Zo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sungmin Zo has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Hyun Lee
Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
6 shared publications - Kyung Hoon Min
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine Korea University Guro Hospital, Korea University College of Medicine Seoul Republic of Korea
5 shared publications - Sang-Heon Kim
Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
4 shared publications - Bo-Guen Kim
Division of Pulmonary Medicine, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
3 shared publications - Hye Yun Park
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
3 shared publications - Ji-Yong Moon
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea
3 shared publications
Latest Publications
- 13 November 2026
- Published by Elsevier in Journal of Psychiatric Research
Impact of the COVID-19 Pandemic on the Odds of Suicidality in Individuals with Asthma
- 13 November 2026
- Published by Elsevier in Journal of Psychiatric Research
Impact of the COVID-19 Pandemic on the Odds of Suicidality in Individuals with Asthma
- Open Access
- 21 April 2026
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 56 (8) , 952-955
Racial Differences in Patterns of Long‐Term Conditions Among Adults With Asthma
Summary: Racial differences exist in patterns of long‐term condition among adults with asthma. These differences may have implications for asthma management and outcomes.
- 21 April 2026
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 56 (8) , 952-955
Open AccessRacial Differences in Patterns of Long‐Term Conditions Among Adults With Asthma
Summary: Racial differences exist in patterns of long‐term condition among adults with asthma. These differences may have implications for asthma management and outcomes.
- Open Access
- 1 April 2026
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
- Vol. 89 (2) , 235-244
Addressing Low Physical Activity in Chronic Obstructive Pulmonary Disease: The Importance of Patients’ Symptom Perception
Background: Pulmonary rehabilitation (PR) is a key intervention for chronic obstructive pulmonary disease (COPD); however, adherence remains suboptimal, particularly in patients with low physical activity (PA) despite preserved physical capacity (PC). This study aimed to identify factors associated with low PA, with a focus on patient-reported outcomes (PROs).Methods: In this prospective study, COPD patients were categorized according to daily moderate-to-vigorous PA measured using Fitbit devices: ≥30 minutes/day (‘Do do’) and <30 minutes/day (‘Don’t do’). Baseline characteristics, pulmonary function, and exercise capacity assessed by 6-minute walk distance (6MWD) were evaluated. PROs included the modified Medical Research Council (mMRC) dyspnea scale, COPD Assessment Test (CAT), and Patient Health Questionnaire-9 (PHQ-9). Logistic regression analysis was performed to identify factors independently associated with low PA.Results: Among 96 patients, 44 were classified as ‘Do do’ and 52 as ‘Don’t do.’ The ‘Don’t do’ group showed significantly lower 6MWD (424 m vs. 488 m, p=0.005) and lower forced expiratory volume in 1 second (46.73% vs. 54.48%, p=0.005). They also reported higher dyspnea scores (mMRC 1.77 vs. 1.30, p=0.019). Greater breathlessness measured by CAT was independently associated with low PA (odds ratio, 1.31; 95% confidence interval, 1.06 to 1.62), even after adjustment for 6MWD and pulmonary function. This association persisted in patients with preserved PC.Conclusion: Low PA in COPD is influenced not only by objective physical limitations but also by subjective symptom burden, particularly dyspnea. Integrating PROs into PR assessment may facilitate identification of barriers and improve adherence to rehabilitation programs.
- 1 April 2026
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
- Vol. 89 (2) , 235-244
Open AccessAddressing Low Physical Activity in Chronic Obstructive Pulmonary Disease: The Importance of Patients’ Symptom Perception
Background: Pulmonary rehabilitation (PR) is a key intervention for chronic obstructive pulmonary disease (COPD); however, adherence remains suboptimal, particularly in patients with low physical activity (PA) despite preserved physical capacity (PC). This study aimed to identify factors associated with low PA, with a focus on patient-reported outcomes (PROs).Methods: In this prospective study, COPD patients were categorized according to daily moderate-to-vigorous PA measured using Fitbit devices: ≥30 minutes/day (‘Do do’) and <30 minutes/day (‘Don’t do’). Baseline characteristics, pulmonary function, and exercise capacity assessed by 6-minute walk distance (6MWD) were evaluated. PROs included the modified Medical Research Council (mMRC) dyspnea scale, COPD Assessment Test (CAT), and Patient Health Questionnaire-9 (PHQ-9). Logistic regression analysis was performed to identify factors independently associated with low PA.Results: Among 96 patients, 44 were classified as ‘Do do’ and 52 as ‘Don’t do.’ The ‘Don’t do’ group showed significantly lower 6MWD (424 m vs. 488 m, p=0.005) and lower forced expiratory volume in 1 second (46.73% vs. 54.48%, p=0.005). They also reported higher dyspnea scores (mMRC 1.77 vs. 1.30, p=0.019). Greater breathlessness measured by CAT was independently associated with low PA (odds ratio, 1.31; 95% confidence interval, 1.06 to 1.62), even after adjustment for 6MWD and pulmonary function. This association persisted in patients with preserved PC.Conclusion: Low PA in COPD is influenced not only by objective physical limitations but also by subjective symptom burden, particularly dyspnea. Integrating PROs into PR assessment may facilitate identification of barriers and improve adherence to rehabilitation programs.
- 18 March 2026
- Published by Elsevier in Respiratory Medicine
- Vol. 256, 108782
Bidirectional association between chronic periodontitis and bronchiectasis: A nationwide, population-based cohort study
- 18 March 2026
- Published by Elsevier in Respiratory Medicine
- Vol. 256, 108782
Bidirectional association between chronic periodontitis and bronchiectasis: A nationwide, population-based cohort study
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (41)
Investigation of Matrix Metalloproteinase–Related Genetic Variations Associated With Cavity Formation in Pulmonary Tuberculosis
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (41)
Open AccessInvestigation of Matrix Metalloproteinase–Related Genetic Variations Associated With Cavity Formation in Pulmonary Tuberculosis
- Open Access
- 1 July 2025
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 20, 2199-2210
Impact of Low Hand Grip Strength on Quality of Life, Utilization of Healthcare, and Mental Health in Individuals with Airflow Limitation
Purpose: A higher prevalence of sarcopenia has been demonstrated in individuals with airflow limitation (AFL). However, data on the impact of sarcopenia on quality of life, utilization of healthcare, and mental health in individuals with AFL are limited. Patients and methods: We used data from the 2014– 2019 Korea National Health and Nutrition Examination Survey (KNHANES), and participants with AFL were included. Sarcopenia was assessed using hand grip strength (HGS). The outcomes were health-related quality of life (HRQoL), utilization of healthcare, and mental health. The impact of low HGS and outcomes was assessed using multivariable logistic regression analysis. Results: Among participants with AFL, 12.6% had low HGS and the median (interquartile range) of HGS was 22.5 (18.9– 26.1) kg for women and 37.7 (32.9– 42.6) kg for men. After adjusting for confounders, low HGS was associated with a decrease in HRQoL (usual activities: adjusted odds ratio [aOR], 1.70; 95% confidence interval [CI], 1.14– 2.54; pain/discomfort: aOR, 1.44; 95% CI, 1.02– 2.02, anxiety/depression: aOR, 1.59; 95% CI, 1.05– 2.41), and increased perceived stress (aOR, 1.77; 95% CI, 1.24– 2.53). In the subgroup analysis, the impact of low HGS on HRQoL, utilization of healthcare, and mental health was more evident in the reduced lung function and inactive physical activity groups. Conclusion: Overall, low HGS was associated with decreased quality of life and worsening mental health in participants with AFL. Our findings underscore the importance of muscle strength for HRQoL, particularly in those with impaired lung function and sedentary lifestyles, suggesting that regular physical activity including muscle-strengthening exercises may improve HRQoL. Plain Language Summary: People with chronic lung disease often have a higher prevalence of sarcopenia, but it is unclear how this affects their daily life and mental health. In this study, we analyzed national health data from Korea and found that among people with airflow limitation, low hand grip strength was more likely to be associated with poorer quality of life, higher stress levels, and increased use of healthcare services. These issues were more pronounced in people with reduced lung function and low physical activity. Our findings underscore the importance of muscle strength for better quality of life, particularly in those with impaired lung function and sedentary lifestyles, suggesting that regular physical activity including muscle-strengthening exercises may improve quality of life.
- 1 July 2025
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 20, 2199-2210
Open AccessImpact of Low Hand Grip Strength on Quality of Life, Utilization of Healthcare, and Mental Health in Individuals with Airflow Limitation
Purpose: A higher prevalence of sarcopenia has been demonstrated in individuals with airflow limitation (AFL). However, data on the impact of sarcopenia on quality of life, utilization of healthcare, and mental health in individuals with AFL are limited. Patients and methods: We used data from the 2014– 2019 Korea National Health and Nutrition Examination Survey (KNHANES), and participants with AFL were included. Sarcopenia was assessed using hand grip strength (HGS). The outcomes were health-related quality of life (HRQoL), utilization of healthcare, and mental health. The impact of low HGS and outcomes was assessed using multivariable logistic regression analysis. Results: Among participants with AFL, 12.6% had low HGS and the median (interquartile range) of HGS was 22.5 (18.9– 26.1) kg for women and 37.7 (32.9– 42.6) kg for men. After adjusting for confounders, low HGS was associated with a decrease in HRQoL (usual activities: adjusted odds ratio [aOR], 1.70; 95% confidence interval [CI], 1.14– 2.54; pain/discomfort: aOR, 1.44; 95% CI, 1.02– 2.02, anxiety/depression: aOR, 1.59; 95% CI, 1.05– 2.41), and increased perceived stress (aOR, 1.77; 95% CI, 1.24– 2.53). In the subgroup analysis, the impact of low HGS on HRQoL, utilization of healthcare, and mental health was more evident in the reduced lung function and inactive physical activity groups. Conclusion: Overall, low HGS was associated with decreased quality of life and worsening mental health in participants with AFL. Our findings underscore the importance of muscle strength for HRQoL, particularly in those with impaired lung function and sedentary lifestyles, suggesting that regular physical activity including muscle-strengthening exercises may improve HRQoL. Plain Language Summary: People with chronic lung disease often have a higher prevalence of sarcopenia, but it is unclear how this affects their daily life and mental health. In this study, we analyzed national health data from Korea and found that among people with airflow limitation, low hand grip strength was more likely to be associated with poorer quality of life, higher stress levels, and increased use of healthcare services. These issues were more pronounced in people with reduced lung function and low physical activity. Our findings underscore the importance of muscle strength for better quality of life, particularly in those with impaired lung function and sedentary lifestyles, suggesting that regular physical activity including muscle-strengthening exercises may improve quality of life.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (39) , e247
Risk of Stroke in COVID-19 Survivors With Asthma: A Nationwide, Population-Based Cohort Study
Zo S, et al. J Korean Med Sci. 2025 Aug;40:e247. https://doi.org/10.3346/jkms.2025.40.e247
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (39) , e247
Open AccessRisk of Stroke in COVID-19 Survivors With Asthma: A Nationwide, Population-Based Cohort Study
Zo S, et al. J Korean Med Sci. 2025 Aug;40:e247. https://doi.org/10.3346/jkms.2025.40.e247
- Open Access
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (1) , 135-146
COVID-19 and Long-term Risk of Ischemic Heart Disease in Asthma
Zo S, et al. Allergy Asthma Immunol Res. 2025 Jan;17(1):135-146. https://doi.org/10.4168/aair.2025.17.1.135
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (1) , 135-146
Open AccessCOVID-19 and Long-term Risk of Ischemic Heart Disease in Asthma
Zo S, et al. Allergy Asthma Immunol Res. 2025 Jan;17(1):135-146. https://doi.org/10.4168/aair.2025.17.1.135
- Open Access
- 1 October 2024
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
- Vol. 87 (4) , 440-450
Secondary Immunodeficiency and Non-cystic Fibrosis Bronchiectasis
Bronchiectasis is a chronic respiratory disease characterized by abnormal dilation of the bronchi that causes cough, sputum, and recurrent infections. As it may be associated with various respiratory or systemic diseases, a critical aspect of managing bronchiectasis is to identify the underlying cause. Immunodeficiency is a rare but important cause of bronchiectasis, and its treatability is a significant trait for bronchiectasis management. While primary immunodeficiencies in bronchiectasis are well recognized, secondary immunodeficiencies remain under-reported and under-researched. Secondary immunodeficiencies may result from various diseases and conditions, such as hematologic malignancies, human immunodeficiency virus infection, renal transplantation, or the use of immunosuppressive drugs, and may contribute to the occurrence of bronchiectasis. Recurrent pulmonary and/or extrapulmonary infections in bronchiectasis may indicate the presence of secondary immunodeficiency in patients with these underlying conditions. For treatment, examining the underlying condition, managing bronchiectasis adequately, and prophylactic antibiotics (e.g., macrolide) and/or supplementary immunoglobulin G therapy may provide potential benefits. Considering the projected increase in the prevalence of secondary immunodeficiencies and bronchiectasis, future guidelines and research on the diagnosis and optimized treatment are needed.
- 1 October 2024
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
- Vol. 87 (4) , 440-450
Open AccessSecondary Immunodeficiency and Non-cystic Fibrosis Bronchiectasis
Bronchiectasis is a chronic respiratory disease characterized by abnormal dilation of the bronchi that causes cough, sputum, and recurrent infections. As it may be associated with various respiratory or systemic diseases, a critical aspect of managing bronchiectasis is to identify the underlying cause. Immunodeficiency is a rare but important cause of bronchiectasis, and its treatability is a significant trait for bronchiectasis management. While primary immunodeficiencies in bronchiectasis are well recognized, secondary immunodeficiencies remain under-reported and under-researched. Secondary immunodeficiencies may result from various diseases and conditions, such as hematologic malignancies, human immunodeficiency virus infection, renal transplantation, or the use of immunosuppressive drugs, and may contribute to the occurrence of bronchiectasis. Recurrent pulmonary and/or extrapulmonary infections in bronchiectasis may indicate the presence of secondary immunodeficiency in patients with these underlying conditions. For treatment, examining the underlying condition, managing bronchiectasis adequately, and prophylactic antibiotics (e.g., macrolide) and/or supplementary immunoglobulin G therapy may provide potential benefits. Considering the projected increase in the prevalence of secondary immunodeficiencies and bronchiectasis, future guidelines and research on the diagnosis and optimized treatment are needed.
- Open Access
- 4 September 2023
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 44 (1) , 92-96
In Vitro Activity of Benzimidazole (SPR719) Against Clinical Isolates of Nontuberculous Mycobacteria With and Without Clarithromycin or Amikacin Resistance
Dae Hun Kim, Ph.D.*, Sungmin Zo, M.D.*, Su-Young Kim, Ph.D., and Byung Woo Jhun, M.D., Ph.D.. Ann Lab Med 2024;44:92-6. https://doi.org/10.3343/alm.2024.44.1.92
- 4 September 2023
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 44 (1) , 92-96
Open AccessIn Vitro Activity of Benzimidazole (SPR719) Against Clinical Isolates of Nontuberculous Mycobacteria With and Without Clarithromycin or Amikacin Resistance
Dae Hun Kim, Ph.D.*, Sungmin Zo, M.D.*, Su-Young Kim, Ph.D., and Byung Woo Jhun, M.D., Ph.D.. Ann Lab Med 2024;44:92-6. https://doi.org/10.3343/alm.2024.44.1.92